制阻燃剂与内分泌相关癌症风险之间的关联:系统性审查和元分析
Chengchen Shen1, Kui Zhang2, Jingyi Shi1
1Department of Physiology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, People's Republic of China.
Toxicology letters
|February 22, 2024
概括
制阻燃剂 (BFR) 与乳腺癌风险增加有关. 暴露于BDE-28,一种特定的BFR,可能会增加与内分泌有关的癌症风险,这需要进一步调查因果关系.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 在瘤学瘤学.
背景情况:
- 内分泌相关癌症 (乳腺癌,甲状腺癌等) 的发病率上升. ) 的情况.
- 制阻燃剂 (BFR) 是已知的有毒物质,具有潜在的致癌作用.
- 流行病学证据将BFR暴露与内分泌癌症风险联系在一起是有限的.
研究的目的:
- 进行元分析,评估BFR暴露与内分泌相关癌症风险之间的关联.
- 综合现有的关于BFR和癌症的流行病学数据.
- 为了确定特定的BFR或与癌症风险增加相关的暴露水平.
主要方法:
- 在PubMed,谷歌学者和科学网的系统文献搜索.
- 15个病例控制和嵌套病例控制研究的元分析 (3468个病例,4187个对照).
- 使用几率比率 (OR) 和95%置信区间 (CI) 评估风险;评估异质性和出版偏差.
主要成果:
- 在脂肪组织中的BFR暴露与乳腺癌风险增加之间发现了显著的关联.
- 对于BFR暴露和甲状腺癌风险没有发现显著的关联.
- 总体而言,BFR暴露与内分泌相关癌症风险增加有关,特别是较高水平的BDE-28.
结论:
- 暴露于BFR是乳腺癌的重要危险因素.
- 低含量的BDE-28暴露可能会显著增加与内分泌有关的癌症风险.
- 需要进一步的研究来建立因果关系和理解机制.
相关概念视频
Types of Toxins
1.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.7K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Halogenation of Alkenes
15.6K
Halogenation is the addition of chlorine or bromine across the double bond in an alkene to yield a vicinal dihalide. The reaction occurs in the presence of inert and non-nucleophilic solvents, such as methylene chloride, chloroform, or carbon tetrachloride.
Consider the bromination of cyclopentene. Molecular bromine is polarized in the proximity of the π electrons of cyclopentene. An electrophilic bromine atom adds across the double bond, forming a cyclic bromonium ion intermediate.
Consider the bromination of cyclopentene. Molecular bromine is polarized in the proximity of the π electrons of cyclopentene. An electrophilic bromine atom adds across the double bond, forming a cyclic bromonium ion intermediate.
15.6K
Biological Effects of Radiation
15.5K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.5K
Hazard Ratio
122
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
122


